Photodynamic Therapy 2021

Edited by
October 2022
238 pages
  • ISBN978-3-0365-5352-8 (Hardback)
  • ISBN978-3-0365-5351-1 (PDF)

This book is a reprint of the Special Issue Photodynamic Therapy 2021 that was published in

Biology & Life Sciences
Chemistry & Materials Science
Medicine & Pharmacology

Photodynamic therapy (PDT) is a light-based photochemistry process. The illumination of a photoactivatable molecule (also called photosensitizer) with visible or near infrared light produces reactive oxygen toxic species to destroy tumor cells. This treatment modality leads to highly targeted actions, because reactive oxygen species are produced only where light is applied. Light is not harmful, nor is the photoactivable molecule. Only the combination of three elements (photosensitizer, oxygen, and light) is required to induce photo-oxidation reactions. PDT has proven to be a promising modality in many medical applications including cutaneous condition, infectious diseases, and various cancers at different stages. This book is a reprint of the Special Issue  "Photodynamic Therapy 2021" that was published in Pharmaceuticals.

  • Hardback
License and Copyright
© 2022 by the authors; CC BY-NC-ND license
β-mannose-conjugated chlorin e6; talaporfin sodium; glioblastoma; U251; photodynamic therapy; PDT; photodynamic therapy; laser; ceramics; bacteria; decontamination; cross-linking agents; fluorescent dyes; oxidation reduction; photochemistry; photosensitizing agents; protein conformation; Rose Bengal; photodynamic therapy; protoporphyrin IX; pyropheophorbide-a; Photofrin®; absorption; fluorescence; singlet oxygen; 5-aminolevulinic acid; 5-ALA; dALA; δALA; PpIX; protoporphyrin IX; photodynamic therapy; PDT; actinic keratosis; illumination time; incubation time; photodynamic therapy; protoporphyrin IX; dental implant; peri-implantitis; photoantimicrobial chemotherapy; methylene blue; chitosan; curcumin; natural photosensitizer; photodynamic therapy; skin cancer treatment; squamous cell carcinoma; melanoma; normal keratinocytes; liposomes; glioblastoma multiforme; AGuIX®; terbium; gadolinium; photodynamic therapy; X-ray-induced photodynamic therapy; singlet oxygen; photodynamic therapy; chemotherapy; zinc (II) phthalocyanine; tin complex; PDT; methyl aminolevulinate; methylene blue; riboflavin; photosensitizing agents; ultraviolet radiation; skin tumors; prophylactic treatment; hairless mice; photodynamic therapy; photothermal therapy; radiation therapy; immunotherapy; immune checkpoint inhibition; murine models; clinical trials; immunotherapy; photodynamic therapy; programmed death-ligand 1 protein (PD-L1); magnetic nanoparticles; peptide-imprinted polymer; photoinactivation; resistance; antimicrobial agents; SSTI; MDR

Related Books